4/A//SEC Filing
Calabrese Salvatore 4/A
Accession 0001415889-22-005491
CIK 0001819411other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:00 PM ET
Size
4.6 KB
Accession
0001415889-22-005491
Insider Transaction Report
Form 4/AAmended
Calabrese Salvatore
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-19$2.70/sh+3,000$8,100→ 3,000 total
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001851958
Filing Metadata
- Form type
- 4/A
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:00 PM ET
- Size
- 4.6 KB